Is CJC-1295 Legal in the UK and UAE?
CJC-1295 is not a UK controlled substance, but it is prohibited under the WADA Prohibited List (relevant to UK Anti-Doping) and has no MHRA marketing authorisation — lawful to buy as a research reagent, not lawful to sell or use as a human growth-hormone-releasing product.
CJC-1295 is not scheduled as a controlled substance in the UAE and is available through the research-reagent channel only; it has no MOHAP/DHA clinical authorisation.
UK detail
CJC-1295 is a growth-hormone-releasing hormone analogue. It does not appear on the Misuse of Drugs Act schedules, so research purchase and possession is lawful, but it is on the World Anti-Doping Agency Prohibited List, which matters specifically for anyone subject to UK Anti-Doping testing (competitive athletes). It has no UK marketing authorisation, so supply framed around human use — rather than laboratory research — is unlawful under the Human Medicines Regulations 2012.
UAE detail
CJC-1295 is not a scheduled controlled substance in the UAE. As with the other compounds here, it is supplied research-use-only, with human administration falling outside what a research-reagent supplier is authorised to sell for.
This is a general overview, not legal advice, and law in this area can change. For a specific situation, consult a solicitor with life-sciences regulatory experience (UK) or MOHAP/DHA directly (UAE). See our full UK compliance guide and UAE compliance guide for the full legal framework this page summarises.